"We noticed that suddenly the country has become full of MRI". Policy makers' views on diffusion and use of health technologies in Iran

Health Research Policy and Systems

Volumn 8, Issue , 2010, Pages

  Palesh, Mohammad ^a,b,c   Tishelman, Carol ^a,d,e   Fredrikson, Sten ^a   Jamshidi, Hamidreza ^b,f   Tomson, Göran ^a   Emami, Azita ^g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Stockholms Sjukhem Foundation   (Sweden)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g SEATTLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

ARTICLE; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; IRAN; MARKETING; MEDICAL TECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PUBLIC HEALTH; QUALITATIVE RESEARCH; RESOURCE ALLOCATION; SEMI STRUCTURED INTERVIEW;

EID: 77950532761     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-8-9     Document Type: Article

References (40)

1. World Health Organization Health Technologies - The backbone of health services. Geneva World Health Organization., http://www.who.int/eht
2. Levin L, Goeree R, Sikich N, Jorgensen B, Brouwers MC, Easty T, Zahn C. Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience. Int J Technol Assess Health Care 2007, 23(3):299-309. 10.1017/S0266462307070456, 17579931.
3. Basch PF. Technology transfer to the developing world: does new technology have any relevance for developing countries?. Tuber Lung Dis 1993, 74(6):353-358. 10.1016/0962-8479(93)90077-B, 8136487.
4. Bodenheimer T. High and rising healthcare costs. Ann Intern Med 2005, 142:932-937.
5. Wanless D. Security our future health: taking a long term view. , http://www.hm-treasury.gov.uk/wanless
6. Hanney S, Buxton M, Green C, Coulson D, Raftery J. An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technol Assess 2007, 11(53):1-200.
7. Banta D, Jonsson E. History of HTA: Introduction. Int J Technol Assess Health Care 2009, 25(Suppl 1):1-6. 10.1017/S0266462309090321, 19500432.
8. Palesh M, Fredrikson S, Jamshidi H, Jonsson PM, Tomson G. Diffusion of magnetic resonance imaging in Iran. Int J Technol Assess Health Care 2007, 23(2):278-285. 10.1017/S0266462307070377, 17493315.
9. Palesh M, Fredrikson S, Jamshidi H, Tomson G, Petzold M. How is magnetic resonance imaging used in Iran?. Int J Technol Assess Health Care 2008, 24(4):452-458. 10.1017/S0266462308080598, 18828940.
10. Palesh M, Jonsson PM, Jamshidi H, Wettermark B, Tomson G, Fredrikson S. Diffusion of interferon beta in Iran and its utilization in Tehran. Pharmacoepidemiol Drug Saf 2008, 17(9):934-941. 10.1002/pds.1621, 18509835.
11. Banta D, Luce B. Health Care Technology and its Assessment: An International Perspective 1993, Oxford University Press.
12. Goodin DS, Frohman EM, Garmany GP, Halper J, Likosky WH, Lublin FD, Silberberg DH, Stuart WH, Noort S. Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002, 58(2):169-178.
13. Herceptin prescribing information. , http://www.gene.com/gene/products/information/oncology/herceptin/factsheet.html
14. HER hope - Understanding HER2+ Breast Cancer. , http://www.herceptin.com
15. Deputy for Food and Drug, Ministry of Health and Medical Education, Iran National Drug Policy Islamic Republic of Iran. 2004, Deputy for Food and Drug, Ministry of Health and Medical Education, Iran.
16. Nikfar S, Kebriaeezadeh A, Majdzadeh R, Abdollahi M. Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran. BMC Int Health Hum Rights 2005, 5(1):5. 10.1186/1472-698X-5-5, 1145184, 15885139.
17. World Health Organization Health system profile, IR of Iran. Eastern Mediterranean Region Office (EMRO). 2004, World Health Organization.
18. Robson C. Real world research 2002, Massachusetts: Blackwell.
19. Patton MQ. Qualitative research and evaluation methods 2002, London: SAGE.
20. Green J. Qualitative Methods for Health Research 2004, London: SAGE.
21. Ritchie J, Lewis J. Qualitative Research Practice. A Guide for Social Science Students and Researchers 2003, London: SAGE.
22. Pope C, Ziebland S, Mays N. Analysing qualitative data. BMJ 2000, 320:114-116. 10.1136/bmj.320.7227.114, 1117368, 10625273.
23. Corabian P, Hailey D, Harstall C, Juzwishin D, Moga C. Mentoring a developing health technology assessment initiative in Romania: an example for countries with limited experience of assessing health technology. Int J Technol Assess Health Care 2005, 21(4):522-525. 10.1017/S0266462305050737, 16262978.
24. Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet 2001, 358(9280):483-488. 10.1016/S0140-6736(01)05627-6, 11513933.
25. European Observatory on Health Systems and Policies Health Technology Assessment and Health Policy-Making in Europe: Current status, Challenges and Potential. 2008, European Observatory on Health Systems and Policies.
26. European Observatory on Health Systems and Policies Health Technology Assessment: An introduction to objectives, role of evidence, and structure in Europe. 2005, European Observatory on Health Systems and Policies.
27. Gilson L, McIntyre D. The interface between research and policy: Experience from South Africa. Soc Sci Med 2008, 67:748-759. 10.1016/j.socscimed.2008.02.005, 18387723.
28. Black N. Evidence based policy: proceed with care. BMJ 2001, 323:275-279. 10.1136/bmj.323.7307.275, 1120888, 11485961.
29. Hivon M, Lehoux P, Denis JL, Tailliez S. Use of health technology assessment in decision making: Coresponsibility of users and producers?. International Journal of Technology Assessment in Health Care 2005, 21(2):268-275.
30. Buse K, Walt G. Aid coordination for health sector reform: a conceptual framework for analysis and assessment. Health Policy 1996, 38:173-187. 10.1016/0168-8510(96)00855-X, 10162420.
31. Garcia-Prado A, Gonzalez P. Policy and regulatory responses to dual practice in the health sector. Health Policy 2007, 84(2-3):142-152. 10.1016/j.healthpol.2007.03.006, 17449134.
32. Ferrinho P, Van Lerberghe W, Fronteira I, Hipolito F, Biscaia A. Dual practice in the health sector: review of the evidence. Hum Resour Health 2004, 2(1):14. 10.1186/1478-4491-2-14, 529467, 15509305.
33. Mansfield PR, Lexchin J, Wen LS, Grandori L, McCoy CP, Hoffman JR, Ramos J, Jureidini JN. Educating health professionals about drug and device promotion: Advocates recommendations. PLos Med 2006, 3(11):1988-1991.
34. Walt G, Gilson L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan 1994, 9(4):353-370. 10.1093/heapol/9.4.353, 10139469.
35. Eggleston K, Bir A. Physician dual practice. Health Policy 2006, 78:157-166. 10.1016/j.healthpol.2005.09.007, 16253383.
36. Gallego G, Gool VK, Kelleher D. Resource allocation and health technology assessment in Australia: Views from the local level. Int J Technol Assess Health Care 2009, 25(2):134-140. 10.1017/S0266462309090187, 19331706.
37. Perleth M, Gibis B, Gohlen B. A short history of health technology assessment in Germany. Int J Technol Assess Health Care 2009, 25(Suppl 1):112-119. 10.1017/S0266462309090515, 19500440.
38. Rosenau PV. Managing medical technology: lessons for the United States from Quebec and France. International Journal of Health Services 2000, 30(3):617-639. 10.2190/20H5-9N3J-1WC4-NXP7, 11109185.
39. Trubswasser U, Branca F. Nutrition policy is taking shape in Europe. Public Health Nutrition 2009, 12(3):295-306.
40. Stenson B, Syhakhang L, Lundborg CS, Eriksson B, Tomson G. Private pharmacy practice and regulation. A randomized trial in Lao P.D.R. Int J Technol Assess Health Care 2001, 17(4):579-589.